Global X Genomics & Biotechnology ETF (GNOM) Price

Global X Genomics & Biotechnology ETF is offered by Global X, a leading player in the field of passive investments.

The ISIN of Global X Genomics & Biotechnology ETF is US37960A2143.

The total expense ratio of Global X Genomics & Biotechnology ETF is 0.50%, which means that investors pay 50.00 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, Global X Genomics & Biotechnology ETF does not comply with the EU UCITS investor protection directives.

Global X Genomics & Biotechnology ETF tracks the performance of the Solactive Genomics Index.

The current average trading volume of Global X Genomics & Biotechnology ETF is 9,583.37.

Global X Genomics & Biotechnology ETF is domiciled in US.

The fund was launched on 4/5/2019.

The Global X Genomics & Biotechnology ETF mainly invests in Topic companies.

The NAV of Global X Genomics & Biotechnology ETF amounts to 44.30 M USD.

The price-to-book ratio is 3.48.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.